Human iPSC-derived microglia carrying the LRRK2-G2019S mutation show a Parkinson's disease related transcriptional profile and function

携带LRRK2-G2019S突变的人类iPSC衍生小胶质细胞表现出与帕金森病相关的转录谱和功能。

阅读:1
作者:Sohvi Ohtonen ,Luca Giudice ,Henna Jäntti ,Mohammad Feroze Fazaludeen ,Anastasia Shakirzyanova ,Mireia Gómez-Budia ,Nelli-Noora Välimäki ,Jonna Niskanen ,Nea Korvenlaita ,Ilkka Fagerlund ,Jari Koistinaho ,Mahmood Amiry-Moghaddam ,Ekaterina Savchenko ,Laurent Roybon ,Šárka Lehtonen ,Paula Korhonen ,Tarja Malm

Abstract

LRRK2-G2019S is one of the most common Parkinson's disease (PD)-associated mutations and has been shown to alter microglial functionality. However, the impact of LRRK2-G2019S on transcriptional profile of human induced pluripotent stem cell-derived microglia-like cells (iMGLs) and how it corresponds to microglia in idiopathic PD brain is not known. Here we demonstrate that LRRK2-G2019S carrying iMGL recapitulate aspects of the transcriptional signature of human idiopathic PD midbrain microglia. LRRK2-G2019S induced subtle and donor-dependent alterations in iMGL mitochondrial respiration, phagocytosis and cytokine secretion. Investigation of microglial transcriptional state in the midbrains of PD patients revealed a subset of microglia with a transcriptional overlap between the in vitro PD-iMGL and human midbrain PD microglia. We conclude that LRRK2-G2019S iMGL serve as a model to study PD-related effects in human microglia.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。